News Related to Stony Brook University

Related coverage linked through entity extraction aliases.

Oral Listeria Vaccine Enhances Immunotherapy Response in Colorectal Cancer

Feb 24, 2026

Researchers at Stony Brook University developed an oral vaccine using modified Listeria monocytogenes that generates anti-tumor immune responses in the gut and significantly improves colorectal cancer control when combined with checkpoint inhibitors.

Engineered Listeria Bacteria Shows Promise as Cancer Immunotherapy

Feb 13, 2026

Researchers have developed attenuated Listeria bacteria therapies that boost innate immune cells to fight cancer. Two approaches target colorectal cancer and pediatric leukemia, with FDA clearance expected soon for trials in children.